Skip to search formSkip to main contentSkip to account menu

dexmethylphenidate

Known as: D-TMP, d-MPH, d-threo-methylphenidate 
The d-threo-enantiomer of methylphenidate, a central nervous system stimulant, appearing to block the reuptake of norepinephrine and dopamine into… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Barriers to Switching Patients to Second-Line Antiretroviral Treatment Among Clinicians in Tanzania by Peter Charles Mgosha MPH… 
2016
2016
Reduced-Fee Dental Hygiene Treatment and Oral Health Perceptions Among Socioeconomically Deprived Persons by Janeime Asbury MPH… 
2016
2016
Methylphenidate is a frequently used treatment choice in attention deficit hyperactivity disorder. In this paper we will present… 
2015
2015
ABS TRACT Objective: Attention deficit hyperactivity disorder (ADHD) is one of the most frequently seen neuropsychiatric… 
2010
2010
Objectives : The aim of this study was to investigate the effect of the clinical and demographic variables such as body weight… 
2007
2007
Throughout the world, railway systems contribute to improving connections among people and facilitating cargo movement… 
2007
2007
ZusammenfassungIn der vorgestellten Studie wurde die Wirksamkeit von unretardiertem Methylphenidat (MPH) bei der Behandlung von… 
2005
2005
ZusammenfassungWir berichten über eine 44-jährige Patientin mit Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung vom kombinierten… 
2004
2004
L'invention concerne un nouveau procede efficace de preparation de dexmethylphenidate hydrochlorure d'une purete optique elevee… 
2003
2003
SUMMARY In 1937 a serendipitous observation discovered the effects of amphetamines on disruptive behavior. Today, stimulant…